Schroder Investment Management Group Uro Gen Pharma Ltd. Transaction History
Schroder Investment Management Group
- $94.4 Billion
- Q1 2025
A detailed history of Schroder Investment Management Group transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Schroder Investment Management Group holds 303,397 shares of URGN stock, worth $5.39 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
303,397Holding current value
$5.39 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding URGN
# of Institutions
149Shares Held
42.6MCall Options Held
116KPut Options Held
42.1K-
Ubs Asset Management Americas Inc Chicago, IL4.36MShares$77.4 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY3.83MShares$68.1 Million0.69% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.21MShares$56.9 Million0.74% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$40.9 Million0.17% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$38.9 Million0.0% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $404M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...